An improvement of the efficacy of Moxifloxacin HCl for the treatment of bacterial keratitis by the formulation of ocular mucoadhesive microspheres

Scientia Pharmaceutica

Volumn 81, Issue 1, 2012, Pages 259-280

  Dandagi, Panchaxari Mallappa ^a   Belekar, Amit Manohar ^b   Mastiholimath, Vinayak Shivamurthy ^a   Gadad, Anand Panchakshari ^a   Sontake, Vivek Wamanrao ^b   Salian, Prashant Sanjivrao ^b  

^a JAWAHARLAL NEHRU MEDICAL COLLEGE   (India)

^b KDCA's Institute of Pharmacy   (India)

Author keywords

Bacterial keratitis; Microspheres; Moxifloxacin HCl; Mucoadhesion; Ocular

Indexed keywords

CARBOXYMETHYLCELLULOSE; METHYLCELLULOSE; MICROSPHERE; MOXIFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL KERATITIS; BACTERIAL STRAIN; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG EFFICACY; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; EPIPHORA; EYE REDNESS; EYE SWELLING; GROWTH INHIBITION; IN VITRO STUDY; INFRARED SPECTROSCOPY; MALE; MEAN RESIDENCE TIME; MUCOADHESION; NONHUMAN; PARTICLE SIZE; RABBIT; SCANNING ELECTRON MICROSCOPY; SCORING SYSTEM; TOXICITY TESTING; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84875291015     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1204-08     Document Type: Article

References (33)

1. Budai L, Hajdú M, Budai M, Gróf P, Béni S, Noszál B, Klebovich I, Antal I. Gels and liposomes in optimized ocular drug delivery: Studies on ciprofloxacin formulations. Int J Pharm. 2007; 343: 34-40. http://dx.doi.org/10.1016/j.ijpharm.2007.04.013
2. Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 2005; 57: 1595-1639: http://dx.doi.org/10.1016/j.addr.2005.07.005
3. Gupta R. Acute eye conditions. Med J Armed Forces Ind. 2003; 59: 239-241. http://dx.doi.org/10.1016/S0377-1237(03)80016-3
4. Friedlaender M. A review of the causes and treatment of bacterial and allergic conjunctivitis. Clin Ther. 1995; 17: 800-810. http://dx.doi.org/10.1016/0149-2918(95)80058-1
5. Constantinou M, Daniell M, Snibson G, Vu H, Taylor H. Clinical efficacy of Moxifloxacin in the treatment of bacterial keratitis a randomized clinical trial. J Ophtha. 2007; 114: 1622-1629. http://dx.doi.org/10.1016/j.ophtha.2006.12.011
6. Torkildsen G, O'Brien T. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and Moxifloxacin 0.5% ophthalmic solutions: A single-dose randomized, open-label, active-controlled trial in healthy adult volunteers. Clin Ther. 2008; 30: 2005-2014. http://dx.doi.org/10.1016/j.clinthera.2008.10.020
7. Deramo V, Lai J, Fastenberg D, Udell I. Acute endophthalmitis in eyes treated prophylactically with Gatifloxacin and Moxifloxacin. Am J Ophthalmol. 2006; 142: 721-725. http://dx.doi.org/10.1016/j.ajo.2006.05.044
8. Robertson SM, Curtis M, Schlech B, Rusinko A, Owen GR, Dembinska O, Liao J, Dahlin DC. Ocular pharmacokinetics of moxifloxacin after topical treatment ofanimals and humans. Surv Ophthalmol. 2005; 50: S32-S45. http://dx.doi.org/10.1016/j.survophthal.2005.07.001
9. Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea. 2008; 27: 22-27. http://dx.doi.org/10.1097/ICO.0b013e318156caf2
10. Shastri DH, Prajapati ST, Patel LD. Thermo reversible mucoadhesive ophthalmic in situ hydrogel: design and optimization using a combination of polymers. Acta Pharm. 2010; 60: 349-360. http://dx.doi.org/10.2478/v10007-010-0029-4
11. Mali MN, Hajare AA. Ion activated in situ gel system for ophthalmic delivery of Moxifloxacin hydrochloride. Latin Am J Pharm. 2010; 29: 876-882.
12. Cevher E, Orhan Z, Mulazi{dotless}moglu L, Sensoy D, Alper M, Yildiz A, Ozsoy Y. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres. Int J Pharm. 2006; 317: 127-135. http://dx.doi.org/10.1016/j.ijpharm.2006.03.014
13. Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine. 2010; 6: 324-333. http://dx.doi.org/10.1016/j.nano.2009.10.004
14. Somchit MN, Reezal I, Nur E, Mutalib AR. In vitro antimicrobial activity of ethanol and water extracts of cassia alata. J Ethnopharmacology. 2003; 84: 1-4. http://dx.doi.org/10.1016/S0378-8741(02)00146-0
15. OECD guideline. Acute eye irritation/corrosion, test guideline 405. 2002. http://iccvam.niehs.nih.gov/SuppDocs/FedDocs/OECD/OECDtg405.pdf
16. Monanambal E, Arun K, Abdul Hasan SA. Formulation and evaluation of pH-triggered in situ gelling system of levofloxacin. Ind J Pharm Edu Res. 2011; 45: 58-64.
17. National Research Council (NRC), Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC, USA, 1996.
18. Charoo NA, Kohli K, Ali A. Preparation of in situ forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studies. J Pharm Sci. 2003; 92: 407-413. http://dx.doi.org/10.1002/jps.10290
19. Satyanarayan C, Ramanjaneyulu GS, Rao U, Narasimharao DVL, inventors. Process for preparation of Moxifloxacin hydrochloride. United States Patent 2006/0264635 A1. 2006 Nov. 23.
20. Yadav S, Jain S, Prajapati S, Motwani M, Kumar S. Formulation and in vitro and in vivo characterization of acyclovir loaded mucoadhesive microspheres. J Pharm Sci Tech. 2011; 3: 441-447.
21. Arya RKK, Juyal V, Singh R. Development and evaluation of gastro resistant microspheres of pantoprazole. Int J Pharm Pharm Sci. 2010; 2: 112-116.
22. Reddy SS, Shyalaja A. Preparation and In Vitro evaluation of Famotidine mucoadhesive microspheres using different mucoadhesive agents. Sci J Pharm. 2011; 1: 48-56.
23. Rowe RC, Sheskey PJ, Quinn ME. Handbook of Pharm. Excipients. 6th Ed. London: The pharmaceutical press, 2009: 118-121.
24. Lv J, Fang S, Chen L. Preparation and characterization of affinity polymer basic microspheres by soap-free emulsion polymerization. Chin J Polymer Sci. 2009; 27: 101-108. http://dx.doi.org/10.1142/S0256767909003704
25. Gaba P, Singh S, Gaba M, Gupta GD. Galactomannan gum coated mucoadhesive microspheres of glipizide for treatment of type 2 diabetes mellitus: In vitro and in vivo evaluation. Saudi Pharm J. 2011; 19: 143-152. http://dx.doi.org/10.1016/j.jsps.2011.02.001
26. Rathod KS, Nema RK. An insight into ophthalmic drug delivery system. Int J Pharm Sci Drug Res. 2009; 1: 1-5.
27. Nagda C, Chotai N, Patel S, Patel U, Keyur A, Nagda D. Design and characterization of bioadhesive microspheres prepared by double emulsion solvent evaporation method. Acta Pharm Sci. 2009; 51: 261-270.
28. Dhakar RC, Maurya S, Agarwal S, Kumar G, Tilak VK. Design and evaluation of SRM microspheres of metformin hydrochloride. Pharm Glob Int J Compreh Pharm. 2010; 1: 1-5.
29. Kabir AKL, Biswas BK, Rouf ASS. Design, fabrication and evaluation of drug release kinetics from aceclofenac matrix tablets using hydroxypropylmethyl cellulose. Dhaka Univ J Pharm Sci, 2009; 8: 23-30.
30. Sateesha SB, Rao BP, Rajamma AJ, Nargund LVG. Gastroretentive orlistat microspheres: formulation, characterization and in vitro evaluation. Dissolut Technol. 2011; August: 72-79.
31. Costa P, Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001; 13: 123-133. http://dx.doi.org/10.1016/S0928-0987(01)00095-1
32. Singhvi G, Singh M. Review: in vitro drug release characterization models. Int J Pharm Stud Res. 2011; 2: 77-84.
33. Siepmann J, Peppas NA. Higuchi equation: derivation, application, use and misuse. Int J Pharm. 2011; 418: 6-12. http://dx.doi.org/10.1016/j.ijpharm.2011.03.051